Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00777
|
|||||
| Drug Name |
Mizolastine
|
|||||
| Synonyms |
2-((1-(1-(p-Fluorobenzyl)-2-benzimidazolyl)-4-piperidyl)methylamino)-4(3H)-pyrimidinone; 2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one; Allphar brand of mizolastine; Galderma brand of mizolastine; MKC-431; Mistalin; Mistamine; Mizolastina; Mizolastina [INN-Spanish]; Mizolastine (JAN/INN); Mizolastine [INN]; Mizolastinum; Mizolastinum [INN-Latin]; Mizolen; Mizollen; Mizollen (TN); Novag brand of mizolastine; SL 85.0324; SL-85.0324; Sanofi Synthelabo brand of mizolastine; Schwarz brand of mizolastine; Zolim; Zolistam; Zolistan
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antiallergic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C24H25FN6O
|
|||||
| Canonical SMILES |
CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5
|
|||||
| InChI |
InChI=1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32)
|
|||||
| InChIKey |
PVLJETXTTWAYEW-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 108612-45-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 432.5 | Topological Polar Surface Area | 65.8 | ||
| Heavy Atom Count | 32 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
3.2
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.